In our study, by combining metabolism, gut bacteria composition and urinary tract infections, we demonstrated that the enrichment of Intestinibacter may affect IL-17A and thus result to a greater susceptibility to urinary tract infections in patients with stones. Here, IL17A is linked to urinary tract infection.